Los Angeles Capital Management LLC Horizon Therapeutics Public LTD CO Transaction History

Los Angeles Capital Management LLC

$24.7 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 06, 2023	SELL	$98.98 - $115.74 $1.38 Million - $1.61 Million	-13,928 Reduced 16.72%	69,368 $8.03 Million
Q2 2023 Aug 03, 2023	SELL	$96.34 - $112.38 $6.36 Million - $7.42 Million	-66,023 Reduced 44.22%	83,296 $8.57 Million
Q1 2023 May 04, 2023	BUY	$107.32 - $113.5 $376,371 - $398,044	3,507 Added 2.41%	149,319 $16.3 Million
Q4 2022 Feb 06, 2023	SELL	$62.39 - $113.8 $580,476 - $1.06 Million	-9,304 Reduced 6.0%	145,812 $16.6 Million
Q3 2022 Nov 02, 2022	BUY	$58.92 - $84.67 $9.14 Million - $13.1 Million	155,116 New	155,116 $9.6 Million
Q4 2021 Feb 03, 2022	SELL	$98.56 - $119.91 $190,122 - $231,306	-1,929 Closed	0 $0
Q3 2021 Nov 08, 2021	BUY	$91.91 - $110.37 $177,294 - $212,903	1,929 New	1,929 $211,000
Q2 2021 Aug 05, 2021	SELL	$86.24 - $95.92 $471,387 - $524,298	-5,466 Closed	0 $0
Q1 2021 May 05, 2021	SELL	$71.83 - $95.48 $5.5 Million - $7.31 Million	-76,604 Reduced 93.34%	5,466 $503,000
Q4 2020 Feb 04, 2021	BUY	$67.0 - $84.39 $892,373 - $1.12 Million	13,319 Added 19.37%	82,070 $6 Million
Q3 2020 Nov 02, 2020	BUY	$55.23 - $79.93 $970,335 - $1.4 Million	17,569 Added 34.33%	68,751 $5.34 Million
Q2 2020 Aug 05, 2020	BUY	$30.2 - $56.98 $980,110 - $1.85 Million	32,454 Added 173.29%	51,182 $2.84 Million
Q1 2020 May 04, 2020	BUY	$24.87 - $38.56 $129,448 - $200,704	5,205 Added 38.49%	18,728 $555,000
Q4 2019 Feb 07, 2020	SELL	$25.43 - $36.67 $519,662 - $749,351	-20,435 Reduced 60.18%	13,523 $490,000
Q3 2019 Nov 07, 2019	SELL	$23.0 - $27.97 $691,541 - $840,973	-30,067 Reduced 46.96%	33,958 $925,000
Q2 2019 Jul 29, 2019	BUY	$22.81 - $28.48 $1.46 Million - $1.82 Million	64,025 New	64,025 $1.54 Million

Others Institutions Holding HZNP

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

20K

View Full List

About Horizon Therapeutics Public Ltd Co

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

More about HZNP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.

Account